+197.7%
AON vs GSK
+80.1%
+117.6%
-38.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.7% | 0.0% | -1.7% | -1.7% |
| 7D | -6.3% | -3.5% | -2.8% | -5.3% |
| 30D | -14.1% | -3.4% | -10.6% | -13.2% |
| 3M | -9.5% | -8.1% | -1.4% | -7.3% |
| 6M | -4.0% | -11.1% | +7.1% | -1.0% |
| YTD | -13.8% | +0.7% | -14.5% | -14.6% |
| 1Y | -18.3% | +20.1% | -38.4% | -23.5% |
| 3Y | -7.2% | +46.1% | -53.3% | -20.0% |
| 5Y | +7.3% | +48.2% | -40.9% | -9.7% |
| All | +197.7% | +80.1% | +117.6% | +139.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling